Search

Your search keyword '"Pascoal-Xavier MA"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Pascoal-Xavier MA" Remove constraint Author: "Pascoal-Xavier MA"
38 results on '"Pascoal-Xavier MA"'

Search Results

1. Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma

2. Can letrozole be repurposed for the treatment of visceral leishmaniasis?

3. Enhancing the epidemiological surveillance of SARS-CoV-2 using Sanger sequencing to identify circulating variants and recombinants.

4. MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis.

5. Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study.

6. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.

7. Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts.

8. Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.

9. The role of mucosal-associated invariant T cells in visceral leishmaniasis.

10. Anti-mitochondrial Tryparedoxin Peroxidase Monoclonal Antibody-Based Immunohistochemistry for Diagnosis of Cutaneous Leishmaniasis.

12. Phenotypic and Functional Signatures of Peripheral Blood and Spleen Compartments of Cynomolgus Macaques Infected With T. cruzi : Associations With Cardiac Histopathological Characteristics.

13. Potential antigenic targets used in immunological tests for diagnosis of tegumentary leishmaniasis: A systematic review.

14. Histopathological Characterization of Mitral Valvular Lesions from Patients with Rheumatic Heart Disease.

15. Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma.

16. Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

17. Prospection of immunological biomarkers for characterization and monitoring of asymptomatic Leishmania ( Leishmania ) infantum infection.

18. Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment.

19. Laboratorial algorithm for serological diagnosis of visceral leishmaniasis using rK39-ICT, DAT-LPC and FC-Simplex IgG1.

20. Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae.

21. Late-Relapsing Hepatitis after Yellow Fever.

22. Cardiac Involvement by Yellow Fever(from the PROVAR+ Study).

23. Detection of cytomegalovirus, herpes virus simplex, and parvovirus b19 in spontaneous abortion placentas.

24. Genetic variant strains of Leishmania (Viannia) braziliensis exhibit distinct biological behaviors.

25. Disseminated mycosis in a patient with yellow fever.

26. Fcγ-RI, Fcγ-RII and IL-10 as predictive biomarkers for post-therapeutic cicatrization time in monocytes from cutaneous leishmaniasis patients.

27. HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis.

28. Helminths and Cancers From the Evolutionary Perspective.

29. Accomplishing the genotype-specific serodiagnosis of single and dual Trypanosoma cruzi infections by flow cytometry Chagas-Flow ATE-IgG2a.

30. Influenza A Virus as a Predisposing Factor for Cryptococcosis.

31. Flow cytometric-based protocols for assessing anti-MT-2 IgG1 reactivity: High-dimensional data handling to define predictors for clinical follow-up of Human T-cell Leukemia virus type-1 infection.

32. Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system.

33. RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia.

34. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.

35. Social and immunological differences among uninfected Brazilians exposed or unexposed to human immunodeficiency virus-infected partners.

36. Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.

37. Vaccinia virus: shedding and horizontal transmission in a murine model.

38. Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains.

Catalog

Books, media, physical & digital resources